Federal grants to Biochip Labs Inc
Biochip Labs Inc in Cleveland, Ohio received $5.7 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Cardiovascular Diseases Research, with $4.4 million. In fiscal 2025 it was awarded $492,912.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$5.7 million
- Awards5
- Awarded in FY 2025$492,912
- Largest award$2.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $512,578 |
| FY 2022 | 2 | $1.1 million |
| FY 2023 | 2 | $1.8 million |
| FY 2024 | 2 | $1.8 million |
| FY 2025 | 2 | $492,912 |
Programs that fund Biochip Labs Inc
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 3 | $4.4 million |
| Technology, Innovation, and Partnerships | 1 | $1.1 million |
| Engineering | 1 | $256,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $4.4 million |
| National Science Foundation | 2 | $1.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Microfluidic technology for concurrent assessment of red blood cell adhesion and deformability - project summary deformability and non-adherence are the most intrinsic biorheological properties of red blood cells (RBCS), as they play a critical role in modulating rbc perfusion through the microvascu | Cardiovascular Diseases Research | March 25, 2022 | $2.1 million |
| Endothelialized microfluidic assays for emerging therapies in sickle cell disease - project summary sickle cell disease (SCD) afflicts 100,000 americans and millions of people worldwide, and is characterized by anemia, painful vaso-occlusive crises, ischemia, inflammation, significant morbidity, and | Cardiovascular Diseases Research | August 23, 2021 | $2.0 million |
| Sttr phase II: optimized manufacturing and machine learning based automation of endothelium-on-a-chip microfluidic devices for drug screening applications. -the broader impact/commercial potential of this small business technology transfer (STTR) phase II project is to address the unmet need in the | Technology, Innovation, and Partnerships | March 27, 2024 | $1.1 million |
| Manufacturing and analytical validation of the microfluidic impedance red cell assay (MIRCA) for commercial viability - project summary sickle cell disease (SCD) is an autosomal recessive disorder that significantly contributes to morbidity and mortality among affected populations. In individuals wi | Cardiovascular Diseases Research | September 15, 2025 | $312,371 |
| Sttr phase i: standardized and reproducible culture and activation of endothelial cells in microfluidic devices for drug screening applications | Engineering | June 1, 2021 | $256,000 |
Questions people ask
How much federal grant money does Biochip Labs Inc get?
$5.7 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Biochip Labs Inc the most?
The Department of Health and Human Services, with $4.4 million in 3 awards. The National Science Foundation follow.
What is Biochip Labs Inc's largest federal grant?
$2.1 million under Cardiovascular Diseases Research, with its first action in the period on March 25, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Biochip Labs Inc?
Its largest are Cardiovascular Diseases Research, Technology, Innovation, and Partnerships and Engineering.
Other grant recipients in Cleveland
- Case Western Reserve University
- Greater Cleveland Regional Transit Authority
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
- Cuyahoga Metropolitan Housing Authority
- City of Cleveland
- Growth Opportunity Partners, Inc
- Emerald Development & Economic Network Inc
- Cuyahoga County
Largest federal grant recipients in Ohio · Federal grants in Ohio